vs
BJs RESTAURANTS INC（BJRI）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
BJs RESTAURANTS INC的季度营收约是Orthofix Medical Inc.的1.6倍（$355.4M vs $219.9M），BJs RESTAURANTS INC净利率更高（3.6% vs -1.0%，领先4.6%），BJs RESTAURANTS INC同比增速更快（3.2% vs 2.0%），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 2.6%）
BJ's Restaurants Inc.是美国休闲连锁餐饮企业，旗下门店遍布美国多个地区，主打招牌深盘披萨、精酿啤酒、手工鸡尾酒及各类美式家常餐食，服务家庭聚餐、朋友聚会等多元客群，主打轻松舒适的用餐氛围。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
BJRI vs OFIX — 直观对比
营收规模更大
BJRI
是对方的1.6倍
$219.9M
营收增速更快
BJRI
高出1.2%
2.0%
净利率更高
BJRI
高出4.6%
-1.0%
两年增速更快
OFIX
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $355.4M | $219.9M |
| 净利润 | $12.6M | $-2.2M |
| 毛利率 | 74.5% | 71.1% |
| 营业利润率 | 3.1% | 0.2% |
| 净利率 | 3.6% | -1.0% |
| 营收同比 | 3.2% | 2.0% |
| 净利润同比 | -24.2% | 92.4% |
| 每股收益（稀释后） | $0.58 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BJRIOFIX
| Q4 25 | $355.4M | $219.9M | ||
| Q3 25 | $365.6M | $205.6M | ||
| Q2 25 | $348.0M | $203.1M | ||
| Q1 25 | — | $193.6M | ||
| Q4 24 | $325.7M | $215.7M | ||
| Q3 24 | $349.9M | $196.6M | ||
| Q2 24 | $337.3M | $198.6M | ||
| Q1 24 | — | $188.6M |
净利润BJRIOFIX
| Q4 25 | $12.6M | $-2.2M | ||
| Q3 25 | $22.2M | $-22.8M | ||
| Q2 25 | $13.5M | $-14.1M | ||
| Q1 25 | — | $-53.1M | ||
| Q4 24 | $-2.9M | $-29.1M | ||
| Q3 24 | $17.2M | $-27.4M | ||
| Q2 24 | $7.7M | $-33.4M | ||
| Q1 24 | — | $-36.0M |
毛利率BJRIOFIX
| Q4 25 | 74.5% | 71.1% | ||
| Q3 25 | 75.2% | 72.2% | ||
| Q2 25 | 75.0% | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | 73.4% | 69.0% | ||
| Q3 24 | 74.3% | 68.7% | ||
| Q2 24 | 74.8% | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率BJRIOFIX
| Q4 25 | 3.1% | 0.2% | ||
| Q3 25 | 5.8% | -8.3% | ||
| Q2 25 | 4.3% | -7.9% | ||
| Q1 25 | — | -25.2% | ||
| Q4 24 | -0.8% | -5.3% | ||
| Q3 24 | 3.8% | -9.6% | ||
| Q2 24 | 2.4% | -12.5% | ||
| Q1 24 | — | -15.6% |
净利率BJRIOFIX
| Q4 25 | 3.6% | -1.0% | ||
| Q3 25 | 6.1% | -11.1% | ||
| Q2 25 | 3.9% | -6.9% | ||
| Q1 25 | — | -27.4% | ||
| Q4 24 | -0.9% | -13.5% | ||
| Q3 24 | 4.9% | -13.9% | ||
| Q2 24 | 2.3% | -16.8% | ||
| Q1 24 | — | -19.1% |
每股收益（稀释后）BJRIOFIX
| Q4 25 | $0.58 | $-0.05 | ||
| Q3 25 | $0.97 | $-0.57 | ||
| Q2 25 | $0.58 | $-0.36 | ||
| Q1 25 | — | $-1.35 | ||
| Q4 24 | $-0.13 | $-0.76 | ||
| Q3 24 | $0.72 | $-0.71 | ||
| Q2 24 | $0.32 | $-0.88 | ||
| Q1 24 | — | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.8M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $366.2M | $450.0M |
| 总资产 | $1.0B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BJRIOFIX
| Q4 25 | $23.8M | $82.0M | ||
| Q3 25 | $26.0M | $62.9M | ||
| Q2 25 | $19.0M | $65.6M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | $18.4M | $83.2M | ||
| Q3 24 | $16.2M | $30.1M | ||
| Q2 24 | $18.8M | $26.4M | ||
| Q1 24 | — | $27.0M |
总债务BJRIOFIX
| Q4 25 | — | — | ||
| Q3 25 | $60.5M | $157.2M | ||
| Q2 25 | $85.5M | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | $66.5M | $157.0M | ||
| Q3 24 | $63.5M | $118.5M | ||
| Q2 24 | $58.0M | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益BJRIOFIX
| Q4 25 | $366.2M | $450.0M | ||
| Q3 25 | $386.6M | $442.5M | ||
| Q2 25 | $371.5M | $458.3M | ||
| Q1 25 | — | $458.3M | ||
| Q4 24 | $376.2M | $503.1M | ||
| Q3 24 | $386.5M | $525.9M | ||
| Q2 24 | $375.4M | $546.0M | ||
| Q1 24 | — | $570.3M |
总资产BJRIOFIX
| Q4 25 | $1.0B | $850.6M | ||
| Q3 25 | $1.0B | $832.6M | ||
| Q2 25 | $1.0B | $837.2M | ||
| Q1 25 | — | $823.1M | ||
| Q4 24 | $1.0B | $893.3M | ||
| Q3 24 | $1.0B | $867.9M | ||
| Q2 24 | $1.0B | $882.0M | ||
| Q1 24 | — | $906.0M |
负债/权益比BJRIOFIX
| Q4 25 | — | — | ||
| Q3 25 | 0.16× | 0.36× | ||
| Q2 25 | 0.23× | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | 0.18× | 0.31× | ||
| Q3 24 | 0.16× | 0.23× | ||
| Q2 24 | 0.15× | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流BJRIOFIX
| Q4 25 | — | $27.7M | ||
| Q3 25 | $62.3M | $12.4M | ||
| Q2 25 | $4.6M | $11.6M | ||
| Q1 25 | — | $-18.4M | ||
| Q4 24 | $27.3M | $23.7M | ||
| Q3 24 | $20.2M | $11.7M | ||
| Q2 24 | $22.3M | $9.0M | ||
| Q1 24 | — | $-18.6M |
自由现金流BJRIOFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | $41.9M | $2.5M | ||
| Q2 25 | $-12.1M | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | $7.6M | $15.2M | ||
| Q3 24 | $735.0K | $6.3M | ||
| Q2 24 | $448.0K | $-360.0K | ||
| Q1 24 | — | $-29.1M |
自由现金流率BJRIOFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | 11.5% | 1.2% | ||
| Q2 25 | -3.5% | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | 2.3% | 7.0% | ||
| Q3 24 | 0.2% | 3.2% | ||
| Q2 24 | 0.1% | -0.2% | ||
| Q1 24 | — | -15.4% |
资本支出强度BJRIOFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | 5.6% | 4.8% | ||
| Q2 25 | 4.8% | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | 6.0% | 4.0% | ||
| Q3 24 | 5.6% | 2.7% | ||
| Q2 24 | 6.5% | 4.7% | ||
| Q1 24 | — | 5.6% |
现金转化率BJRIOFIX
| Q4 25 | — | — | ||
| Q3 25 | 2.80× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 2.89× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BJRI
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
